Concepedia
Statistics
Publications
9
Citations
1.4K
H-Index
Active since
1997
Affiliations
Intercept Pharmaceuticals (United States)(Current)
FGK Clinical Research
Universitat de Barcelona
Virginia Commonwealth University
University of Alberta
O. Böhm is an author at Intercept Pharmaceuticals (United States) specializing in medicine, pharmacology, and pediatrics.
Publications per year
1997–2017
Efficacy of Obeticholic Acid in Patients With Primary Biliary Cirrhosis and Inadequate Response to Ursodeoxycholic Acid
Gideon M. Hirschfield, Andrew L. Mason, Velimir A. Luketic et al. · Gastroenterology · 2014 · 565 citations · Full text
Pharmacy, Pharmacology, Pharmacotherapy +15
Early determinants of childhood overweight and adiposity in a birth cohort study: role of breast-feeding
Karl E. Bergmann, Renate L. Bergmann, Rüdiger von Kries et al. · International Journal of Obesity · 2003 · 301 citations
Medicine, Child Health, Pediatrics +16
A randomized trial of obeticholic acid monotherapy in patients with primary biliary cholangitis
Kris V. Kowdley, Velimir A. Luketic, Roger W. Chapman et al. · Hepatology · 2017 · 277 citations · Full text
Medicine, Pharmacology, Pharmacotherapy +16
2 FARNESOID-X RECEPTOR AGONISTS: A NEW CLASS OF DRUGS FOR THE TREATMENT OF PBC? AN INTERNATIONAL STUDY EVALUATING THE ADDITION OF INT-747 TO URSODEOXYCHOLIC ACID
Andrew L. Mason, Velimir A. Luketic, K. Lindor et al. · Journal of Hepatology · 2010 · 77 citations
Medicine, Medicinal Chemistry, Pharmacology +6
28 AN INTERNATIONAL STUDY EVALUATING THE FARNESOID X RECEPTOR AGONIST OBETICHOLIC ACID AS MONOTHERAPY IN PBC
Kris V. Kowdley, David Jones, Velimir A. Luketic et al. · Journal of Hepatology · 2011 · 63 citations · Full text
Medicine, Pharmacology, Pharmacotherapy +4
1–5 of 9